How CSRC Rules Are Reshaping Overseas Listing Strategies

Introduction

Access to international capital markets for China-related companies has not disappeared. It has been restructured.

As of May 22, 2026, the CSRC has publicly disclosed 50 filing applications relating to U.S. listings. Given that companies may file on a confidential basis, the actual number of applications is likely higher. Based on CSRC filing notices, 14 U.S.-related approvals were issued in 2025 and one in 2026, covering both IPOs and de-SPAC transactions[1].

Approvals have been issued on a selective and paced basis, reflecting the structured nature of the regime. The CSRC issued a filing notice for Smart Logistics Global Limited in April 2025[2], followed by Londian Wason New Energy Tech Inc. in December 2025[3], and most recently DSC Holdings Ltd., a Zhejiang-based used car dealer software company, in April 2026.

What the data shows is not a closed market. It shows a market that is selective, paced, and structurally calibrated. The implications for how issuers plan and execute overseas listings are significant.

I. The Traditional Playbook No Longer Applies

For many years, overseas listings for China-related companies followed a predictable sequence: establish an offshore holding structure, prepare the prospectus, engage international underwriters, clear comments with the SEC or exchange, price the transaction. If financial metrics met listing standards and governance was appropriately structured, execution risk was largely market-driven.

That framework no longer reflects current reality.

Since the CSRC overseas listing filing regime came into effect on March 31, 2023, accessing international capital markets is no longer solely an offshore regulatory exercise. In substance, it has become a coordinated process across jurisdictions. Chinese regulatory review now runs in parallel with overseas regulator and exchange review, and the interaction between these tracks increasingly determines transaction feasibility, timing, and structural design.

This is not a procedural adjustment. It is a strategic reorientation.

II. Scope Is the First Determination, Not the Last

The most common miscalculation in today’s market is underestimating the reach of the filing regime.

The CSRC regime applies not only to direct overseas listings by PRC-incorporated entities, but also to indirect listings where the offshore issuer’s primary operations, assets, revenues, or management are substantially located in China. The analysis is substance-based. Offshore incorporation alone does not determine regulatory treatment. Establishing a Cayman or BVI holding company does not automatically place a company outside the filing regime if the commercial center of gravity remains within China.

Some issuers evaluate international expansion, operational diversification, or geographic rebalancing as part of a broader corporate strategy, and that can be commercially sound. What it cannot be is a mechanical solution to regulatory classification. Regulators assess economic substance and operational reality. Oversimplifying this analysis introduces regulatory exposure and execution risk that compounds as a transaction progresses.

Correctly assessing scope at the outset is not optional. It is foundational.

III. Transaction Timelines Require Structural Revision

Even where scope is clear, the filing regime introduces a second regulatory track that must be built into the critical path from the beginning.

The filing process requires comprehensive alignment between PRC submissions and overseas offering documents. Ownership transparency, historical restructurings, control arrangements, and industry-specific regulatory considerations are all subject to review. Supplemental information requests are common, and multiple rounds of iteration have become the norm rather than the exception.

What many issuers initially approach as an administrative filing frequently evolves into a substantive review cycle. The practical implication is direct: overseas listing is no longer a single-regulator process. It is a coordinated cross-jurisdiction execution strategy, and internal preparation, documentation discipline, and advisor coordination must begin materially earlier than under prior market conditions.

Transaction timelines that do not reflect this reality are, in the most straightforward sense, incomplete.

IV. Market Behavior Reflects a More Disciplined Environment

Market data reinforces the structural shift.

U.S. IPO activity involving China-related issuers has become more measured since 2025, reflecting a more structured regulatory framework rather than a contraction in market access. The broader U.S. IPO market continues to function, demonstrating that access remains available for issuers that are properly structured and well prepared.

Recent CSRC filing notices confirm that overseas listings continue to receive regulatory clearance, including transactions targeting the U.S. market. The April 2026 approval of DSC Holdings Ltd. for a Nasdaq listing is the most recent confirmation. The channel remains open. The requirements for successfully navigating it have become more substantive.

The takeaway is not that overseas listings are unavailable. It is that successful execution now requires stronger preparation, clearer structure, and earlier regulatory alignment than the prior regime demanded. In this context, alternative listing pathways such as SPAC mergers have attracted renewed attention among China-related issuers. While the regulatory framework is identical, SPAC structures can offer greater flexibility in transaction timing and valuation negotiation, and for companies seeking to optimize their transaction structure within the existing regulatory framework, that flexibility carries meaningful strategic value.

V. The Strategic Consequence

The costliest mistake issuers continue to make is treating CSRC filing as a late-stage procedural requirement.

It is not. The filing regime influences corporate structure, extends transaction timelines, shapes advisor selection, and can determine whether a transaction progresses at all. Issuers that recognize this early and plan accordingly operate with a materially different execution profile than those that do not.

In today’s environment, overseas listing strategy must be integrated into long-term corporate planning. Structural decisions regarding asset location, governance architecture, and operational footprint should be evaluated years in advance of a public offering, not months before filing. For boards considering access to U.S. capital markets, this also means assessing how future financings, follow-on offerings, convertible transactions, and other capital markets activities will interact with ongoing filing requirements.

The issuers that execute successfully are not those who react to regulatory requirements late in the process. They are those who build regulatory alignment into their structure and documentation from the outset.

Conclusion

The CSRC overseas listing regime did not close the door to international capital markets. It raised the bar for passing through it.

The review is more substantive. The planning horizon is longer. The structural requirements are more exacting. Issuers that align strategy, structure, and documentation early will continue to execute. Those operating under outdated assumptions will encounter delay, uncertainty, and avoidable transaction risk.

In 2026, an overseas listing for a China-related company is no longer simply a capital markets transaction. It is a structural regulatory strategy, one that begins well before the first draft of a prospectus.

Author:

WK Khor

Analyst

 

References:

1. CSRC (2026): China Securities Regulatory Commission
2. CSRC (2025): Smart Logistics Global Limited
3. CSRC (2025): LONDIAN WASON NEW ENERGY TECH INC.
4. CSRC (2026): DSC Holdings Ltd.